P554: GILTERITINIB VERSUS SALVAGE CHEMOTHERAPY FOR RELAPSED/REFRACTORY FLT3-MUTATED ACUTE MYELOID LEUKEMIA: A PHASE 3, RANDOMIZED, MULTICENTER, OPEN-LABEL TRIAL IN ASIA. (23rd June 2022) - Wang, J.; Jiang, B.; Li, J.; Liu, L.; Du, X.; Jiang, H.; Hu, J.; Yuan, M.; Sakatani, T.; Kadokura, T.; Takeuchi, M.; Izuka, S.; et al.